Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with ...

In epidemiological, genetic, and intervention studies, mixed dyslipidaemia, characterised by elevated concentrations of total ...

The GLP-1 agonist has shown convincing benefits in yet another population, patients with peripheral arterial disease, in a ...

Blood sugar monitoring has never been more convenient, thanks to the latest advancements in technology. For those managing diabetes, having a reliable ...

The "Diabetes Monitoring, Treatment and Drug Delivery Market Size, Share & Trends Analysis | United States | 2025-2031 | MedSuite | Includes: Insulin & GLP-1, Continuous Glucose Monitoring and 7 more" ...

The Diabetic Care Devices Market is projected to grow from $16.6 billion in 2024 to $26.8 billion by 2029, at a CAGR of 10.1%. This report provides a comprehensive analysis of diabetes monitoring ...

You may have a blood glucose test in a doctor’s office, laboratory, or with a fingerstick meter at home. When you eat carbohydrates, your body converts them into glucose for energy. Having too ...

POC diagnostic devices, such as glucose monitors and cholesterol testing kits, are revolutionizing healthcare by enabling patients to manage their health more effectively. These technologies reduce ...

Hundreds of thousands of people still using old radio teleswitch service (RTS) meters could be left without electricity or hot water from this summer, experts have warned. RTS meters were ...

New research has examined how accurate continuous glucose monitors (CGM) are in comparison to capillary blood glucose measurements (CBGMs). The study has found that CGM can overestimate both fasting ...

Results from a phase 3 clinical trial published in The Lancet Infectious Diseases showed efficacy against symptomatic dengue of 75·8% for DENV-1 and 59·7% for DENV-2. Data on serotypes 3 and 4 remain ...